Alan Gold: While the share
prices of life science companies are certainly dynamic, we believe the foundation of our business and the overall life science industry could not be more solid.
Represented a variety
of life science and health care
companies, as well as individual employees, officers, consultants and medical professionals, in criminal and civil litigation by multiple U.S. Attorneys Offices, DOJ, HHS - OIG, qui tam Relators, state attorneys general and national Medicaid fraud control units, regarding alleged «off - label» promotion, unlawful inducements and other sales, marketing,
pricing and development activities.